Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
5-day change
1st Jan Change
25.74
USD
-1.38%
+12.75%
-61.71%
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the Medifast First Quart...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance
Apr. 30
MT
Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report
Apr. 30
MT
Top Premarket Decliners
Apr. 30
MT
North American Morning Briefing : More Earnings Roll In; Fed Decision Looms
Apr. 30
DJ
Transcript : Medifast, Inc., Q1 2024 Earnings Call, Apr 29, 2024
Apr. 29
Earnings Flash (MED) MEDIFAST Reports Q1 EPS $0.66
Apr. 29
MT
Earnings Flash (MED) MEDIFAST Reports Q1 Revenue $174.7M, vs. Street Est of $173.5M
Apr. 29
MT
Medifast, Inc. Provides Earnings Guidance for the Second Quarter of 2024
Apr. 29
CI
Medifast, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 29
CI
Medifast, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 20
CI
Transcript : Medifast, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Feb. 20
Earnings Flash (MED) MEDIFAST Posts Q4 EPS $1.09, vs. Street Est of $0.96
Feb. 20
MT
Earnings Flash (MED) MEDIFAST Reports Q4 Revenue $191M, vs. Street Est of $184.2M
Feb. 20
MT
Medifast Provides Earnings Guidance for the First Quarter of 2024
Feb. 20
CI
Medifast, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 20
CI
Health Care Climbs After Fed Policy Move -- Health Care Roundup
Dec. 13
DJ
Medifast, LifeMD Collaborate to Offer Weight Management Solution; Medifast Scraps Quarterly Dividend
Dec. 13
MT
Transcript : LifeMD, Inc., Medifast, Inc. - Special Call
Dec. 13
Medifast's Board of Directors Elect to Discontinue the Company's Quarterly Cash Dividend
Dec. 13
CI
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, Inc
Dec. 13
CI
Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013.
Nov. 06
CI
Medifast, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 06
CI
Transcript : Medifast, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Nov. 06
Earnings Flash (MED) MEDIFAST Posts Q3 Revenue $235.9M, vs. Street Est of $232.1M
Nov. 06
MT
Medifast, Inc. Provides Earnings Guidance for the Full Year 2023
Nov. 06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
More about the company
Last Close Price
25.74
USD
Average target price
25
USD
Spread / Average Target
-2.87%
Consensus
1st Jan change
Capi.
-61.71% 275M +11.85% 8.05B +5.29% 7.59B +2.63% 6.07B -2.80% 3.85B -11.22% 3.55B -7.04% 1.28B -32.50% 1.03B +12.52% 971M -11.19% 907M
Special Foods & Wellbeing Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1